Matteo Brusamolino

Dr. Matteo Brusamolino


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2026 in Journal of Cardiovascular Medicine
Verified
Journal Article
Closed access
MBMatteo Brusamolino
Matteo Brusamolino
GAGiorgio Agati
Giorgio Agati
FNFlavia Nicoli
Flavia Nicoli
RMRocco Mollace
Rocco Mollace
EBErika Bertella
Erika Bertella
Export

25 May 2026 in Medicina
Verified
Journal Article
Open access
PDF file
MBMatteo Brusamolino
Matteo Brusamolino
FCFrancesco Catagnano
Francesco Catagnano
MMMaria Lo Monaco
Maria Lo Monaco
SMSilvia Malara
Silvia Malara
MCMatteo De Carli
Matteo De Carli
EBErika Bertella
Erika Bertella
Infiltrative cardiomyopathies comprise a heterogeneous spectrum of hereditary and acquired diseases characterised by the accumulation of pathological substrates within the myocardium, ultimately resulting in progressive impairment of cardiac function and the development of heart failure. Across these conditions, atrial fibrillation is a frequent and clinically relevant complication, contributing to symptom burden, heart failure progression, and thromboembolic risk. Structural, functional, and electrical atrial remodelling, collectively referred to as atrial cardiomyopathy, emerges as a common pathophysiological substrate linking myocardial infiltration to atrial fibrillation and adverse cardiovascular outcomes. Multi-modality cardiac imaging enables comprehensive assessment of atrial cardiomyopathy, offering mechanistic insights into the atrial substrate of atrial fibrillation, with potential impact on the clinical management of this group of diseases. This review summarises contemporary evidence on atrial fibrillation in infiltrative cardiomyopathies, with a particular focus on the role of non-invasive multimodal imaging in the evaluation of atrial cardiomyopathy.

27 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
FNFlavia Nicoli
Flavia Nicoli
RMRocco Mollace
Rocco Mollace
ECElona Collaku
Elona Collaku
MMMaria Lo Monaco
Maria Lo Monaco
MLMargherita Celeste Licastro
Margherita Celeste Licastro
EBErika Bertella
Erika Bertella
Advances in computed tomography (CT) technology have made it possible to perform non-invasive imaging with detailed characterization and quantification of the myocardium. Cardiac CT (CCT) has emerged as a technique useful for providing deeper insights into cardiovascular diseases, as a valuable alternative when cardiac magnetic resonance imaging or echocardiography are contraindicated, technically unfeasible, inconclusive, or non-diagnostic. Cardiac tissue characterization by the advances in CT technology lead to differentiate myocardial tissue types with high resolution. CCT allows the assessment of tissue properties such as myocardial perfusion, fibrosis and fat infiltration, which are critical in diagnosing ischemic heart disease, microvascular obstruction, heart failure, cardiomyopathies, and other cardiac conditions 1. Thin surgical complications and prosthesis studies are possible through high resolution scanners, allowing to detect HALT, pannus, thrombosis, endocarditis, abscesses and other characterizations. The use of contrast agents, along with advanced imaging techniques such as photon-counting CT, allows for high-resolution imaging of tissue heterogeneity, making it a valuable tool for non-invasive evaluation. Dual-energy computed tomography (DECT) has emerged as a transformative tool in the non-invasive assessment of cardiac tissue, enabling a more precise characterization of myocardial structures and pathologies. Employing two distinct energy levels, it provide unique advantages in tissue differentiation through the energy-dependent attenuation of various tissues, allowing for better delineation of tissue properties such as fat, fibrosis, calcification, and water content, improving also quantitative imaging and iodine mapping. Furthermore, new methodologies like CT-based tissue characterization models and artificial intelligence algorithms are enhancing the accuracy of differentiating normal and pathological cardiac tissues. The integration of cardiac CT with other imaging modalities, such as cardiac magnetic resonance (CMR), is also highlighted as a promising approach for comprehensive cardiac tissue assessment in several clinical settings. [*] Aim and scope of the Special Issue: This paper reviews the current techniques for cardiac tissue characterization using CT, explores the role of texture analysis, and discusses the challenges in achieving precise tissue differentiation, outlining the current applications and future perspective of cardiac CT in myocardial tissue characterization.